Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. Fifteen patients with inoperable stage ...

We report the case of a 54-year-old woman with multiple sclerosis who was treated with delayed-release dimethyl fumarate (DMF; Tecfidera, Biogen Idec) and who died on October 13, 2014, from ...

Fumaric acid esters, which are prescribed for the treatment of psoriasis and multiple sclerosis, are considered to have a favorable risk profile. However, treatment-related progressive multifocal ...

National Institutes of Health researchers shared new details about idiopathic CD4 lymphocytopenia (ICL), a rare immune deficiency that leaves people vulnerable to infectious diseases, autoimmune ...

We retrospectively analyzed 56 consecutive patients with relapsed or refractory indolent B-NHL and MCL who received bendamustine (Treakisym) with or without rituximab at our institution between 2011 ...

Idiopathic CD4 T Lymphocytopenia (ICL) is a rare immunological syndrome defined by persistently low CD4+ T-cell counts, typically below 300 cells/µL, in the absence of human immunodeficiency virus ...

Researchers at the University of Rochester Medical Center have conducted a study suggesting that having a low white blood cell count (lymphocytopenia) prior to exposure to severe acute respiratory ...

ROCKVILLE, Md.--(BUSINESS WIRE)--NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation ...

Inoculation of humans with wild or attenuated myxoviruses induces transient alterations in lymphocyte count and function. The effects of A/New Jersey/76 virus, a killed influenza virus vaccine, on ...

A new study suggests the need for caution in switching from fingolimod to a B cell–depleting anti-CD20 treatment such as ocrelizumab for patients with multiple sclerosis (MS). Italian researchers ...